4.04MMarket Cap-218P/E (TTM)
0.8200High0.7500Low257.06KVolume0.7700Open0.8190Pre Close200.84KTurnover5.22%Turnover RatioLossP/E (Static)5.05MShares6.180052wk High0.74P/B3.94MFloat Cap0.477252wk Low--Dividend TTM4.93MShs Float40500.0000Historical High--Div YieldTTM8.55%Amplitude0.4772Historical Low0.7810Avg Price1Lot Size
Quoin Pharmaceuticals Stock Forum
📊⚡️📊
📊⚡️📊
Whats happening here? hmmm
👀 👀 👀
Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
Quoin Pharmaceuticals (NASDAQ: QNRX) has begun testing QRX003 in a pediatric patient with Netherton Syndrome (NS) at Children's Health Ireland in Dublin, led by Dr. Alan Irvine. The company plans to expand testing to include three additional pediatric patients in Spain. QRX003 is currently being evaluated in two late-stage clinical trials, with promising r...
No comment yet